Journal of Medical Case Reports
|
Viewing options:Associated material:Related literature:- Articles citing this article
- Other articles by authors
- Related articles/pages
Tools:Post to:
|
Case reportLessons from Mycobacterium avium complex-associated pneumonitis: a case reportVictor Zota1 , Sheryn M Angelis2 , Armando E Fraire1 , Ciaran McNamee3 , Shasta Kielbasa4 and Daniel H Libraty2,4  1
Department of Pathology, Division of Infectious Disease, University of Massachusetts Medical School, Worcester, MA, USA 2
Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA 3
Department of Surgery, University of Massachusetts Medical School, Worcester, MA, USA 4
Center for Infectious Disease and Vaccine Research, University of Massachusetts Medical School, Worcester, MA, USA author email corresponding author email
Journal of Medical Case Reports 2008,
2:152doi:10.1186/1752-1947-2-152 Abstract
Introduction
Mycobacterium avium complex (MAC) is an increasingly recognized cause of pulmonary disease in immunocompetent individuals. An acute form of MAC lung disease, MAC-associated pneumonitis, has generally been associated with the use of hot tubs. There is controversy in the literature about whether MAC-associated pneumonitis is a classic hypersensitivity pneumonitis or is a direct manifestation of mycobacterial infection.
Case presentation
We report the second case in the literature of MAC-associated pneumonitis not related to the use of hot tubs. The source of MAC in a 52-year-old immunocompetent patient was an intrapulmonary cyst containing numerous acid-fast bacilli. The patient developed disseminated miliary nodules throughout both lung fields. Histological examination of resected lung tissue revealed well-formed, acid-fast negative granulomas composed predominantly of CD4+ T-cells and CD68+ histiocytes. The granulomas were strongly positive for tumor necrosis factor-α, a pro-inflammatory cytokine.
Conclusion
The attempt to classify MAC-associated pneumonitis as either a classic hypersensitivity pneumonitis or a direct manifestation of mycobacterial infection is not particularly useful. Our case demonstrates that MAC-associated pneumonitis is characterized by a vigorous T-helper 1-like, pro-inflammatory, immune response to pulmonary mycobacterial infection. The immunopathology provides a rationale for clinical studies of anti-MAC therapy with the addition of anti-inflammatory agents (for example, corticosteroids) to hasten the resolution of infection and symptoms. |